You are here:--
Antibacterial drugs: Clinical development for non-developers
Part 1: Traditional development – tiers A and B


Antibacterial drugs: Clinical development for non-developers
Part 1: Traditional development – tiers A and B


Speaker: David Shlaes – Anti-infectives consulting, retired

Moderator: Laura Piddock – Head of Scientific Affairs, GARDP

In this presentation we introduce the relationship between the discovery phase and later clinical development. We discuss in some depth traditional clinical development pathways (tiers A and B) focusing on the non-inferiority trial design.


We hosted this live webinar with David Shlaes and Laura Piddock on June 13, 2018.

If you have questions or comments, please let us know. Do so by submitting them via the ‘Talk to an expert’ feature or contact us per email: revive@gardp.org.

2019-08-23T08:13:49+00:00